Answers are grounded in this paper and cite their sources.
Randomized trials suggest improved survival in patients with refractory medulloblastoma using new drug strategies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Donzé et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: